Integrating Supportive Care Into Everyday Practice

News
Video

Being proactive and quickly identifying when a patient may need the supportive care team is the best way to integrate this field into whole-person care.

Declan Walsh, MD, spoke about the importance of integrating supportive care into regular check-ins and follow-ups with other oncology specialties. Supportive and palliative care as a field may come in many different forms; Walsh emphasized how important it is for clinicians to know about the benefits and opportunities of this space.

Walsh gave numerous ways on how this specialty can be integrated into everyday care, including being involved in tumor boards and having a comprehensive care team. Additionally, he would like early recognition of a patient’s needs so that supportive care can be brought in at an appropriate time.

Walsh is chair of the Department of Supportive Oncology at Atrium Health Levine Cancer.

Transcript:

[Supportive care is] a 2-way street. Those of us who are interested in providing supportive oncology services should be very willing to engage in the sharp end of cancer care so that we are accessible, we respond quickly, and we are part of the comprehensive clinical care team. [We are] building these ideas into, for example, tumor boards, where at a tumor board meeting, not only is radiation oncology represented in medical oncology but also supportive oncology. We take a comprehensive view of that person’s case and of their management of that disease. Then, from our colleagues’ point of view, whether they’re surgical oncologists or medical oncologists, there’s been a cultural change. People are much more appreciative of the services now and much more understanding of their importance. What we would like to see is early recognition of the patient’s needs by our clinician colleagues so that the supportive oncology services can get in right at the beginning of the illness trajectory [and] we can have the greatest impact and the best collaboration with all our clinical colleagues, irrespective of what their discipline may be.

Recent Videos
Trials at scale can be conducted in middle-income, low-middle-income, and even lower-income countries if you organize a trial ecosystem.
For example, you have a belt of certain diseases or genetic disorders that you come across, such as sickle cell disease or thalassemia, that are more prevalent in these areas.
Talent shortages in the manufacturing and administration of cellular therapies are problems that must be addressed at the level of each country.
Point-of-care manufacturing, scalable manufacturing, and bringing the cost down [can help].
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
A consolidated database may allow providers to access information on a patient’s prior treatments and genetic abnormalities all in 1 place.
A study presented at ASTRO 2025 evaluated the feasibility of using a unified cancer database to consolidate information gathered across 14 institutions.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 2025 ESMO Annual Congress, from hot topics and emerging trends to travel recommendations.
Physical therapists may play a key role in patient care before, during, and after treatment for cancer, according to Alison Ankiewicz, PT, DPT.
Related Content